GSA CAPITAL PARTNERS LLP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$249,000
+13.7%
30,247
-9.5%
0.03%0.0%
Q2 2022$219,000
+0.5%
33,410
-5.2%
0.03%
+50.0%
Q3 2021$218,000
+26.7%
35,232
+5.3%
0.02%
-77.1%
Q2 2020$172,000
-47.7%
33,447
-63.2%
0.10%
+17.1%
Q1 2020$329,00090,9720.08%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$23,481,0000.99%
Cormorant Asset Management, LP 1,000,000$5,940,0000.23%
WealthTrust Axiom LLC 22,347$132,0000.06%
SECTORAL ASSET MANAGEMENT INC 100,000$594,0000.05%
Virtu Financial LLC 24,577$146,0000.02%
PDT Partners, LLC 61,839$367,0000.02%
SABBY MANAGEMENT, LLC 26,039$155,0000.02%
MGO ONE SEVEN LLC 10,000$59,0000.01%
WINTON GROUP Ltd 45,208$269,0000.01%
Ancora Advisors LLC 36,350$216,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders